RecruitingNCT01137643

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Tissue Procurement For Hematolymphoid Conditions

Sponsor

UNC Lineberger Comprehensive Cancer Center

Enrollment

15,000 participants

Start Date

Jul 1, 2009

Study Type

OBSERVATIONAL

Conditions

Lymphoma Leukemia Myelodysplastic Syndromes Lymphoproliferative Disorder Chronic Myeloproliferative Disorders Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic/Myeloproliferative Neoplasms Nonmalignant Neoplasm

Summary

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.

Eligibility

Min Age: 18 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This study collects blood, tissue, and body fluid samples from patients with blood cancers (such as leukemia, lymphoma, or myeloma) at the University of North Carolina to support research into understanding and treating these diseases. **You may be eligible if...** - You have been diagnosed with a blood or immune system cancer, including leukemia (acute or chronic), lymphoma (Hodgkin or non-Hodgkin), multiple myeloma, myelodysplastic syndrome, aplastic anemia, or related conditions - You are receiving care at the UNC hematology/oncology or stem cell transplant clinics **You may NOT be eligible if...** - No formal exclusion criteria are listed — eligibility is based on your diagnosis and where you receive care Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERbiologic sample preservation procedure

All samples collected during routine clinical care.

OTHERcytology specimen collection procedure

All Samples collected during routine clinical care.

Locations(1)

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

Chapel Hill, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01137643

Related Trials

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT052379863 locations

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

NCT0532019824 locations

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

NCT063031931 location

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

NCT0425631771 locations

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment

NCT0495389721 locations